Nova Patents
AT352304T

Optically pure (-) norcisapride for treating digestive tract disorders

Abstract

(-) - Norcisapride, or a, substantially free of its (+) stereoisomer, for use in a therapeutic method pharmaceutically acceptable salts.

Term

Term ended

Expired 17 May 2016, 10.4 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

25 members in 11 offices

This recordMember, by publication datePriority claim1 more office is in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
48557095United States of AmericaA

Members25

Family members, oldest first
DocumentOfficeKind
CA2224005A1CanadaA1
WO9640133A1World Intellectual Property Organization (WIPO)A1
AU5753396AAustraliaA
US5712293AUnited States of AmericaA
EP0831821A1European Patent Office (EPO)A1
US5877189AUnited States of AmericaA
JPH11510477AJapanA
AU720407B2AustraliaB2
US6156770AUnited States of AmericaA
US6313144B1United States of AmericaB1
EP0831821B1European Patent Office (EPO)B1
AT271870TAustriaT
ATE271870T1AustriaT1
DE69633016D1GermanyD1
EP1462104A1European Patent Office (EPO)A1
DK0831821T3DenmarkT3
PT831821EPortugalE
DE69633016T2GermanyT2
ES2222480T3SpainT3
EP1462104B1European Patent Office (EPO)B1
AT352304TThis recordAustriaT
ATE352304T1AustriaT1
DE69636877D1GermanyD1
DE69636877T2GermanyT2
ES2276194T3SpainT3